JP2024514277A5 - - Google Patents
Info
- Publication number
- JP2024514277A5 JP2024514277A5 JP2023565368A JP2023565368A JP2024514277A5 JP 2024514277 A5 JP2024514277 A5 JP 2024514277A5 JP 2023565368 A JP2023565368 A JP 2023565368A JP 2023565368 A JP2023565368 A JP 2023565368A JP 2024514277 A5 JP2024514277 A5 JP 2024514277A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cancer
- seq
- amino acid
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021090058 | 2021-04-26 | ||
| CNPCT/CN2021/090058 | 2021-04-26 | ||
| CN2021090046 | 2021-04-26 | ||
| CNPCT/CN2021/090049 | 2021-04-26 | ||
| CNPCT/CN2021/090046 | 2021-04-26 | ||
| CN2021090049 | 2021-04-26 | ||
| PCT/CN2022/089388 WO2022228445A1 (en) | 2021-04-26 | 2022-04-26 | Single domain pd-l1 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514277A JP2024514277A (ja) | 2024-03-29 |
| JP2024514277A5 true JP2024514277A5 (https=) | 2025-05-20 |
Family
ID=83847760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565368A Pending JP2024514277A (ja) | 2021-04-26 | 2022-04-26 | 単一ドメインｐｄ－ｌ１抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240209093A1 (https=) |
| EP (1) | EP4330287A4 (https=) |
| JP (1) | JP2024514277A (https=) |
| CN (1) | CN117098780A (https=) |
| WO (1) | WO2022228445A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115925947B (zh) * | 2022-09-27 | 2023-08-22 | 上海百英生物科技股份有限公司 | 一种亲和力成熟方法及抗人pd-l1单域抗体的亲和力成熟 |
| WO2024104373A1 (en) * | 2022-11-15 | 2024-05-23 | I-Mab Biopharma Co., Ltd. | Anti-pd-l1 nanobodies |
| WO2024261338A1 (en) * | 2023-06-22 | 2024-12-26 | Ablynx Nv | Immunoglobulin single variable domains targeting pd-l1 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11377497B2 (en) * | 2017-01-23 | 2022-07-05 | Suzhou Alphamab Co., Ltd. | PD-L1 binding polypeptide or composite |
| EP3816186A4 (en) * | 2018-06-29 | 2022-04-06 | Suzhou Smartnuclide Biopharmaceutical Co., Ltd. | PD-L1 BINDING POLYPEPTIDES AND USE THEREOF |
| TWI793395B (zh) * | 2019-01-25 | 2023-02-21 | 大陸商信達生物製藥（蘇州）有限公司 | 結合ｐｄ-ｌ１和ｏｘ４０的雙特異性抗體 |
| CN112142842B (zh) * | 2019-06-27 | 2023-09-01 | 启愈生物技术(上海)有限公司 | 抗PD-L1纳米抗体及其Fc融合蛋白和应用 |
| CN112409483B (zh) * | 2019-08-22 | 2024-08-27 | 浙江道尔生物科技有限公司 | 抗pd-l1纳米抗体 |
| CN115947846A (zh) * | 2019-09-12 | 2023-04-11 | 普米斯生物技术(珠海)有限公司 | 一种抗pd-l1纳米抗体及其衍生物和用途 |
| CN112574309B (zh) * | 2019-12-05 | 2023-06-16 | 启愈生物技术(上海)有限公司 | 一种抗pd-l1纳米抗体及其用途 |
-
2022
- 2022-04-26 CN CN202280021890.7A patent/CN117098780A/zh active Pending
- 2022-04-26 JP JP2023565368A patent/JP2024514277A/ja active Pending
- 2022-04-26 EP EP22794915.3A patent/EP4330287A4/en active Pending
- 2022-04-26 US US18/288,375 patent/US20240209093A1/en active Pending
- 2022-04-26 WO PCT/CN2022/089388 patent/WO2022228445A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024514277A5 (https=) | ||
| JP2021534762A5 (https=) | ||
| IL302078A (en) | Anti-CCR8 monoclonal antibodies and their uses | |
| JP2022061992A5 (https=) | ||
| JP2025163055A5 (https=) | ||
| JP2024522357A5 (https=) | ||
| JP7399852B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2021511811A5 (https=) | ||
| RU2019128134A (ru) | Антитело против gprc5d и молекула, содержащая антитело | |
| JP2020510653A5 (ja) | Ｃｅａを標的にする多重特異性結合タンパク質 | |
| JP2019531697A5 (https=) | ||
| JP2019536430A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JP2023526774A5 (https=) | ||
| JP2009505676A5 (https=) | ||
| KR20200092302A (ko) | 다중-특이적 항체 및 이들의 제조 및 사용 방법 | |
| JP2010509931A5 (https=) | ||
| JP2023543493A5 (https=) | ||
| JP2023518153A5 (https=) | ||
| JP2023549851A5 (https=) | ||
| JP2024530325A5 (https=) | ||
| JP2021501567A5 (https=) | ||
| JP2020533965A5 (https=) | ||
| CN115605513A (zh) | 一种抗pd-l1和her2的双特异性抗体 | |
| JP2023530036A5 (https=) |